| Oct 21 |
Vertex Pharmaceuticals: A Long-Term Growth Monster
|
| Oct 19 |
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
|
| Oct 18 |
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
|
| Oct 18 |
Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride
|
| Oct 17 |
Vertex coverage resumed by UBS at buy on growth potential
|
| Oct 17 |
Exploring 3 High Growth Tech Stocks in the United States
|
| Oct 14 |
Vertex Pharmaceuticals (VRTX) Ascends But Remains Behind Market: Some Facts to Note
|
| Oct 13 |
Got $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever
|
| Oct 13 |
3 No-Brainer Growth Stocks to Buy in October
|
| Oct 10 |
Vertex to Announce Third Quarter 2024 Financial Results on November 4th
|
